HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

Roberta Zappasodi, Giusi Ruggiero, Carla Guarnotta, Monica Tortoreto, Cristina Tringali, Alessandra Cavanè, Antonello D. Cabras, Lorenzo Castagnoli, Bruno Venerando, Nadia Zaffaroni, Alessandro M. Gianni, Filippo De Braud, Claudio Tripodo, Serenella M. Pupa, Massimo Di Nicola

Research output: Contribution to journalArticle

Abstract

We have shown that human B-cell non-Hodgkin lymphomas (B-NHLs) express heat shock protein (HSP)H1/105 in function of their aggressiveness. Here, we now clarify its role as a functional B-NHL target by testing the hypothesis that it promotes the stabilization of key lymphoma oncoproteins. HSPH1 silencing in 4 models of aggressive B-NHLs was paralleled by Bcl-6 and c-Myc downregulation. In vitro and in vivo analysis of HSPH1-silenced Namalwa cells showed that this effect was associated with a significant growth delay and the loss of tumorigenicity when 10(4) cells were injected into mice. Interestingly, we found that HSPH1 physically interacts with c-Myc and Bcl-6 in both Namalwa cells and primary aggressive B-NHLs. Accordingly, expression of HSPH1 and either c-Myc or Bcl-6 positively correlated in these diseases. Our study indicates that HSPH1 concurrently favors the expression of 2 key lymphoma oncoproteins, thus confirming its candidacy as a valuable therapeutic target of aggressive B-NHLs.

Original languageEnglish
Pages (from-to)1768-1771
Number of pages4
JournalBlood
Volume125
Issue number11
DOIs
Publication statusPublished - Mar 12 2015

Fingerprint

Oncogene Proteins
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Down-Regulation
Cells
Growth
Heat-Shock Proteins
Stabilization
Lymphoma
Testing

ASJC Scopus subject areas

  • Medicine(all)

Cite this

HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma. / Zappasodi, Roberta; Ruggiero, Giusi; Guarnotta, Carla; Tortoreto, Monica; Tringali, Cristina; Cavanè, Alessandra; Cabras, Antonello D.; Castagnoli, Lorenzo; Venerando, Bruno; Zaffaroni, Nadia; Gianni, Alessandro M.; De Braud, Filippo; Tripodo, Claudio; Pupa, Serenella M.; Di Nicola, Massimo.

In: Blood, Vol. 125, No. 11, 12.03.2015, p. 1768-1771.

Research output: Contribution to journalArticle

Zappasodi R, Ruggiero G, Guarnotta C, Tortoreto M, Tringali C, Cavanè A et al. HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma. Blood. 2015 Mar 12;125(11):1768-1771. https://doi.org/10.1182/blood-2014-07-590034
Zappasodi, Roberta ; Ruggiero, Giusi ; Guarnotta, Carla ; Tortoreto, Monica ; Tringali, Cristina ; Cavanè, Alessandra ; Cabras, Antonello D. ; Castagnoli, Lorenzo ; Venerando, Bruno ; Zaffaroni, Nadia ; Gianni, Alessandro M. ; De Braud, Filippo ; Tripodo, Claudio ; Pupa, Serenella M. ; Di Nicola, Massimo. / HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma. In: Blood. 2015 ; Vol. 125, No. 11. pp. 1768-1771.
@article{ef73cc44fd3c40628b1899a33e6abf30,
title = "HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma",
abstract = "We have shown that human B-cell non-Hodgkin lymphomas (B-NHLs) express heat shock protein (HSP)H1/105 in function of their aggressiveness. Here, we now clarify its role as a functional B-NHL target by testing the hypothesis that it promotes the stabilization of key lymphoma oncoproteins. HSPH1 silencing in 4 models of aggressive B-NHLs was paralleled by Bcl-6 and c-Myc downregulation. In vitro and in vivo analysis of HSPH1-silenced Namalwa cells showed that this effect was associated with a significant growth delay and the loss of tumorigenicity when 10(4) cells were injected into mice. Interestingly, we found that HSPH1 physically interacts with c-Myc and Bcl-6 in both Namalwa cells and primary aggressive B-NHLs. Accordingly, expression of HSPH1 and either c-Myc or Bcl-6 positively correlated in these diseases. Our study indicates that HSPH1 concurrently favors the expression of 2 key lymphoma oncoproteins, thus confirming its candidacy as a valuable therapeutic target of aggressive B-NHLs.",
author = "Roberta Zappasodi and Giusi Ruggiero and Carla Guarnotta and Monica Tortoreto and Cristina Tringali and Alessandra Cavan{\`e} and Cabras, {Antonello D.} and Lorenzo Castagnoli and Bruno Venerando and Nadia Zaffaroni and Gianni, {Alessandro M.} and {De Braud}, Filippo and Claudio Tripodo and Pupa, {Serenella M.} and {Di Nicola}, Massimo",
year = "2015",
month = "3",
day = "12",
doi = "10.1182/blood-2014-07-590034",
language = "English",
volume = "125",
pages = "1768--1771",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11",

}

TY - JOUR

T1 - HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

AU - Zappasodi, Roberta

AU - Ruggiero, Giusi

AU - Guarnotta, Carla

AU - Tortoreto, Monica

AU - Tringali, Cristina

AU - Cavanè, Alessandra

AU - Cabras, Antonello D.

AU - Castagnoli, Lorenzo

AU - Venerando, Bruno

AU - Zaffaroni, Nadia

AU - Gianni, Alessandro M.

AU - De Braud, Filippo

AU - Tripodo, Claudio

AU - Pupa, Serenella M.

AU - Di Nicola, Massimo

PY - 2015/3/12

Y1 - 2015/3/12

N2 - We have shown that human B-cell non-Hodgkin lymphomas (B-NHLs) express heat shock protein (HSP)H1/105 in function of their aggressiveness. Here, we now clarify its role as a functional B-NHL target by testing the hypothesis that it promotes the stabilization of key lymphoma oncoproteins. HSPH1 silencing in 4 models of aggressive B-NHLs was paralleled by Bcl-6 and c-Myc downregulation. In vitro and in vivo analysis of HSPH1-silenced Namalwa cells showed that this effect was associated with a significant growth delay and the loss of tumorigenicity when 10(4) cells were injected into mice. Interestingly, we found that HSPH1 physically interacts with c-Myc and Bcl-6 in both Namalwa cells and primary aggressive B-NHLs. Accordingly, expression of HSPH1 and either c-Myc or Bcl-6 positively correlated in these diseases. Our study indicates that HSPH1 concurrently favors the expression of 2 key lymphoma oncoproteins, thus confirming its candidacy as a valuable therapeutic target of aggressive B-NHLs.

AB - We have shown that human B-cell non-Hodgkin lymphomas (B-NHLs) express heat shock protein (HSP)H1/105 in function of their aggressiveness. Here, we now clarify its role as a functional B-NHL target by testing the hypothesis that it promotes the stabilization of key lymphoma oncoproteins. HSPH1 silencing in 4 models of aggressive B-NHLs was paralleled by Bcl-6 and c-Myc downregulation. In vitro and in vivo analysis of HSPH1-silenced Namalwa cells showed that this effect was associated with a significant growth delay and the loss of tumorigenicity when 10(4) cells were injected into mice. Interestingly, we found that HSPH1 physically interacts with c-Myc and Bcl-6 in both Namalwa cells and primary aggressive B-NHLs. Accordingly, expression of HSPH1 and either c-Myc or Bcl-6 positively correlated in these diseases. Our study indicates that HSPH1 concurrently favors the expression of 2 key lymphoma oncoproteins, thus confirming its candidacy as a valuable therapeutic target of aggressive B-NHLs.

UR - http://www.scopus.com/inward/record.url?scp=84924969034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924969034&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-07-590034

DO - 10.1182/blood-2014-07-590034

M3 - Article

C2 - 25573990

AN - SCOPUS:84924969034

VL - 125

SP - 1768

EP - 1771

JO - Blood

JF - Blood

SN - 0006-4971

IS - 11

ER -